Duchenne muscular dystrophy (DMD) is a severe muscle disease that affects afflicted males from a young age, and the mdx mouse is an animal model of this disease. Although new drugs are in development, it is also essential to assess potential dietary therapies that could assist in the management of DMD. In the present study, we compared two diets, high-MUFA diet v. high-PUFA diet, in mdx mice. To generate the high-PUFA diet, a portion of dietary MUFA (oleic acid) was replaced with the dietary essential n-3 PUFA a-linolenic acid (ALA). We sought to determine whether ALA, compared with oleic acid, was beneficial in mdx mice. Consumption of the high-PUFA diet resulted in significantly higher n-3 PUFA content and reduced arachidonic acid content in skeletal muscle phospholipids (PL), while the high-MUFA diet led to higher oleate content in PL. Mdx mice on the high-MUFA diet exhibited 2-fold lower serum creatine kinase activity than those on the high-PUFA diet (P,0·05) as well as a lower body fat percentage (P, 0·05), but no significant difference in skeletal muscle histopathology results. There was no significant difference between the dietary groups with regard to phosphorylated p65 (an inflammatory marker) in skeletal muscle.In conclusion, alteration of PL fatty acid (FA) composition by the high-PUFA diet made mdx muscle more susceptible to sarcolemmal leakiness, while the high-MUFA diet exhibited a more favourable impact. These results may be important for designing dietary treatments for DMD patients, and future work on dietary FA profiles, such as comparing other FA classes and dose effects, is needed.Key words: Dystrophic muscle: n-3 Fatty acids: Olive oil: Flaxseed oil Duchenne muscular dystrophy (DMD) is an X-linked, recessive, degenerative muscle disease, and the mdx mouse is an animal model of DMD (1) . Approximately one in 3500 boys are afflicted with the disease (2) . Compared with those in their wild-type counterparts on the same diet, skeletal muscle phospholipid (PL) in mdx mice exhibit increased oleic acid (18 : 1) and linoleic acid (18 : 2) abundances and reduced DHA (22 : 6) abundance (3) . Results from similar assessments of fatty acid (FA) composition in the muscle of human subjects with DMD are unclear due to a lack of dietary control in these studies (4 -6) as well as issues related to age matching and sample handling (5) . In DMD and the mdx mouse, the skeletal muscle sarcolemma is destabilised as a result of a mutation in the dystrophin gene (2) . Corticosteroid treatment is useful but not sufficiently effective (7) , and lifestyle changes could be additionally useful to favourably alter the trajectory of disease progression. Little is known regarding appropriate dietary recommendations for patients with DMD. However, based on known dysfunction in dystrophic muscle, hypotheses can be generated. The skeletal muscle of DMD patients (8,9) and mdx mice (10 -14) exhibits high levels of inflammation and membrane permeability or leakiness. Therefore, dietary treatments that could alter the...